Paper
Human Papillomavirus Vaccination Among Adults Aged 18-26, 2013-2018.
Published Jan 1, 2020 · Peter Boersma, Lindsey I. Black
NCHS data brief
89
Citations
9
Influential Citations
Abstract
Human papillomavirus (HPV) is a sexually transmitted infection common among both men and women (1). HPV vaccination, which requires multiple doses, was first recommended for girls in 2006 and for boys in 2011 (2,3). Vaccination is routinely recommended at 11-12 years and can be started at age 9 (4). For those not vaccinated at 11-12 years, vaccination is recommended for all persons through age 26 years (4). Two HPV vaccine doses, given 6 to 12 months apart, are recommended if the series is started before age 15. Three doses, to be completed within 6 months, are recommended for those who started vaccination at age 15 or over (4,5). This report describes trends in selfreported HPV vaccination initiation and completion by selected demographic characteristics among adults aged 18-26.
Observational Study
Highly CitedSelf-reported HPV vaccination initiation and completion rates among adults aged 18-26 have increased over time, with more individuals reporting vaccination completion than initiation.
Full text analysis coming soon...